Cargando…

Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses

SIMPLE SUMMARY: The aim of this research was to clarify whether T2WI is efficient for discriminating lung cancer from BPNMs. A T2 contrast ratio (T2 CR) for a pulmonary nodule is defined as the ratio of T2 signal intensity of a pulmonary nodules divided by the T2 signal intensity of the rhomboid mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Usuda, Katsuo, Iwai, Shun, Yamagata, Aika, Iijima, Yoshihito, Motono, Nozomu, Matoba, Munetaka, Doai, Mariko, Hirata, Keiya, Uramoto, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345147/
https://www.ncbi.nlm.nih.gov/pubmed/34359616
http://dx.doi.org/10.3390/cancers13153713
_version_ 1783734560217890816
author Usuda, Katsuo
Iwai, Shun
Yamagata, Aika
Iijima, Yoshihito
Motono, Nozomu
Matoba, Munetaka
Doai, Mariko
Hirata, Keiya
Uramoto, Hidetaka
author_facet Usuda, Katsuo
Iwai, Shun
Yamagata, Aika
Iijima, Yoshihito
Motono, Nozomu
Matoba, Munetaka
Doai, Mariko
Hirata, Keiya
Uramoto, Hidetaka
author_sort Usuda, Katsuo
collection PubMed
description SIMPLE SUMMARY: The aim of this research was to clarify whether T2WI is efficient for discriminating lung cancer from BPNMs. A T2 contrast ratio (T2 CR) for a pulmonary nodule is defined as the ratio of T2 signal intensity of a pulmonary nodules divided by the T2 signal intensity of the rhomboid muscle. There were 52 lung cancers and 47 BPNMs. The optical cutoff value for malignancy was 2.44 for T2 CR by receiver operating characteristic curve. The T2 CR (2.14 ± 0.63) of lung cancers was significantly lower than that (2.68 ± 1.04) of BPNMs (p = 0.0021). The T2 CR of lung cancers was significantly lower than that (2.93 ± 0.26) of pulmonary abscesses (p = 0.011). T2 CR is efficient in discriminating lung cancer from BPNMs. ABSTRACT: Diffusion-weighted imaging is useful for discriminating lung cancer from benign pulmonary nodules and masses (BPNMs), however the diagnostic capability is not perfect. The aim of this research was to clarify whether T2-weighted imaging (T2WI) is efficient in discriminating lung cancer from BPNMs, especially from pulmonary abscesses. A T2 contrast ratio (T2 CR) for a pulmonary nodule is defined as the ratio of T2 signal intensity of a pulmonary nodule divided by the T2 signal intensity of the rhomboid muscle. There were 52 lung cancers and 40 inflammatory BPNMs (mycobacteria disease 12, pneumonia 13, pulmonary abscess 9, other 6) and seven non-inflammatory BPNMs. The T2 CR (2.14 ± 0.63) of lung cancers was significantly lower than that (2.68 ± 1.04) of BPNMs (p = 0.0021). The T2 CR of lung cancers was significantly lower than that (2.93 ± 0.26) of pulmonary abscesses (p = 0.011). When the optical cutoff value of T2 CR was set as 2.44, the sensitivity was 0.827 (43/52), the specificity 0.596 (28/47), the accuracy 0.717 (71/99), the positive predictive value 0.694 (43/62), and the negative predictive value 0.757 (28/37). T2 CR of T2WI is useful in discriminating lung cancer from BPNMs. Pulmonary abscesses, which show strong restricted diffusion in DWI, can be differentiated from lung cancers using T2WI.
format Online
Article
Text
id pubmed-8345147
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83451472021-08-07 Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses Usuda, Katsuo Iwai, Shun Yamagata, Aika Iijima, Yoshihito Motono, Nozomu Matoba, Munetaka Doai, Mariko Hirata, Keiya Uramoto, Hidetaka Cancers (Basel) Article SIMPLE SUMMARY: The aim of this research was to clarify whether T2WI is efficient for discriminating lung cancer from BPNMs. A T2 contrast ratio (T2 CR) for a pulmonary nodule is defined as the ratio of T2 signal intensity of a pulmonary nodules divided by the T2 signal intensity of the rhomboid muscle. There were 52 lung cancers and 47 BPNMs. The optical cutoff value for malignancy was 2.44 for T2 CR by receiver operating characteristic curve. The T2 CR (2.14 ± 0.63) of lung cancers was significantly lower than that (2.68 ± 1.04) of BPNMs (p = 0.0021). The T2 CR of lung cancers was significantly lower than that (2.93 ± 0.26) of pulmonary abscesses (p = 0.011). T2 CR is efficient in discriminating lung cancer from BPNMs. ABSTRACT: Diffusion-weighted imaging is useful for discriminating lung cancer from benign pulmonary nodules and masses (BPNMs), however the diagnostic capability is not perfect. The aim of this research was to clarify whether T2-weighted imaging (T2WI) is efficient in discriminating lung cancer from BPNMs, especially from pulmonary abscesses. A T2 contrast ratio (T2 CR) for a pulmonary nodule is defined as the ratio of T2 signal intensity of a pulmonary nodule divided by the T2 signal intensity of the rhomboid muscle. There were 52 lung cancers and 40 inflammatory BPNMs (mycobacteria disease 12, pneumonia 13, pulmonary abscess 9, other 6) and seven non-inflammatory BPNMs. The T2 CR (2.14 ± 0.63) of lung cancers was significantly lower than that (2.68 ± 1.04) of BPNMs (p = 0.0021). The T2 CR of lung cancers was significantly lower than that (2.93 ± 0.26) of pulmonary abscesses (p = 0.011). When the optical cutoff value of T2 CR was set as 2.44, the sensitivity was 0.827 (43/52), the specificity 0.596 (28/47), the accuracy 0.717 (71/99), the positive predictive value 0.694 (43/62), and the negative predictive value 0.757 (28/37). T2 CR of T2WI is useful in discriminating lung cancer from BPNMs. Pulmonary abscesses, which show strong restricted diffusion in DWI, can be differentiated from lung cancers using T2WI. MDPI 2021-07-23 /pmc/articles/PMC8345147/ /pubmed/34359616 http://dx.doi.org/10.3390/cancers13153713 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Usuda, Katsuo
Iwai, Shun
Yamagata, Aika
Iijima, Yoshihito
Motono, Nozomu
Matoba, Munetaka
Doai, Mariko
Hirata, Keiya
Uramoto, Hidetaka
Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title_full Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title_fullStr Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title_full_unstemmed Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title_short Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses
title_sort novel insights of t2-weighted imaging: significance for discriminating lung cancer from benign pulmonary nodules and masses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345147/
https://www.ncbi.nlm.nih.gov/pubmed/34359616
http://dx.doi.org/10.3390/cancers13153713
work_keys_str_mv AT usudakatsuo novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT iwaishun novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT yamagataaika novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT iijimayoshihito novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT motononozomu novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT matobamunetaka novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT doaimariko novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT hiratakeiya novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses
AT uramotohidetaka novelinsightsoft2weightedimagingsignificancefordiscriminatinglungcancerfrombenignpulmonarynodulesandmasses